3D bioprinting company Organovo has successfully printed human liver and kidney tissue that mimics native tissue. This breakthrough could help address the shortage of donor organs and allow for drug testing without animal or human testing. The WHO cautions that while promising, bioprinted organs are not yet ready for transplantation and more research is needed to understand how they integrate and function when implanted.